🟢 20/20 Biolabs is trading 9.63% up today after shareholders approved 500 million authorized shares

20/20 Biolabs is trading 9.63% up now at $0.51 after shareholders approved increasing authorized common stock from 50 million to 500 million shares.

• The approval was announced on September 18 following the September 16 annual meeting and appears to be the clearest company-specific catalyst for the September 21 move.
• Broader risk-on sentiment may also be supporting small-cap equities, with major U.S. indices higher.